Nothing of interest. I am surprised. But I am picky.
Most of what I have reported on here for IPO research remains on my quote screen. I have owned most of them at one time or another, generally taking small gains. VSI surprised me with downward move, they seem to remain a well run company. I think CPTS could now be a double from when I first watched it, I just never held onto any confidence. DXCM and PODD remain solid, just don't seem to have enough of a target market for what I am looking for. A vaccine that everyone takes every year is much better gamble than a company that makes devices that only a portion of diabetics would use. Solazyme bears some watching though I have not kept up with them well due to price action. SCTY strikes me as high risk, especially before IPO lock up. Perhaps after June 11, with better institutional following I will consider.
CLNE strikes me as one to follow now. There is a lot bad to think about it but the chart screams long term support and buying, I just don't see quality when I scan who owns the thing. If price starts moving up and better owners step in, I'd consider buying. But I have only started to watch this one and need to study more.
I try to swing a big bat. I am studying game film of the pitchers and am waiting for my pitch. I've now got my first ever double and want a game winning grand slam.